Using perampanel to prevent seizures after cardiac arrest
Official title: PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
Run by University of California, San Francisco · NCT06401707 · Data updated 2026-11-12
This study is testing if the medication perampanel can help prevent seizures in patients who have survived a cardiac arrest and are in a coma.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 52 (estimated) |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | May 20, 2024 |
| Main results expected | May 20, 2027 |
| Study ends | October 20, 2027 |
| Registry record updated | July 29, 2026 |
| Trial ID | NCT06401707 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have experienced a non-traumatic out-of-hospital cardiac arrest and are comatose upon ICU admission.
✕Probably not a fit
Patients with acute cerebral hemorrhage, severe kidney or liver impairment, or those diagnosed with seizures prior to the study will not benefit from this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot randomized placebo-controlled clinical trial aims to evaluate the safety and feasibility of using perampanel for preventing post-cardiac arrest status epilepticus (PCARSE) in patients who have experienced a non-traumatic cardiac arrest. The study will enroll comatose patients who have achieved return of spontaneous circulation within 45 minutes of arrest and will randomize them to receive either perampanel or a placebo after admission to the intensive care unit. The primary outcome will focus on the incidence of severe adverse events, while secondary endpoints will assess seizure incidence, frequency, and time to seizure control.
Why it matters
Potential benefit: If successful, this study could significantly reduce the incidence of seizures and improve outcomes for patients recovering from cardiac arrest.
How similar studies have gone: While perampanel has been used in other contexts for seizure management, this specific application in critically ill cardiac arrest patients is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years old * Non-traumatic, out-of-hospital cardiac arrest * Comatose on admission - defined as not following commands * Return of spontaneous circulation (ROSC) within less than 45 minutes from the time of cardiac arrest (defined as the time of 911 or EMS (emergency medical services) witnessed arrest) * Admission to the intensive care unit at Zuckerberg San Francisco General Hospital Exclusion Criteria: * Acute cerebral hemorrhage or infarction * Pregnancy * Prisoner * Severe kidney function impairment with creatinine clearance inferior to 30 ml/min * Severe liver impairment with liver function tests five times above the upper limit of normal * Electrographic or electroclinical seizures diagnosis using American Clinical Neurophysiology criteria confirmed by an epileptologist after cardiac arrest
Where it's running
-
Zuckerberg San Francisco General Hospital
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Edilberto Amorim, MD — University of California, San Francisco
- Study coordinator: Edilberto Amorim, MD
- Email: prosperstudy@ucsf.edu
- Phone: 628-206-3203
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using EEG to guide anesthesia for seizures after cardiac arrest
This study is testing two different ways of using EEG to guide anesthesia in patients who have had a cardiac arrest and are experiencing severe seizures, to see which method works better at controlling those seizures.
-
Creation of a database linking EEG recordings with clinical information for epilepsy patients
This study is creating a database that links brain wave recordings and medical information from epilepsy patients to see if it can help improve treatment and predict seizures better.
-
Recovery after coma from serious brain injury or illness
This observational study will follow adults who are unconscious due to a serious brain illness or injury to see what medical, neurological, psychological, and social factors are linked with recovery over time.
-
Augmented kidney clearance in neurocritical care
This project will test whether adults in the neuro-ICU with severe brain injury, stroke, seizures, or brain infections have faster kidney clearance (ARC) that can lower antiseizure and antibiotic drug levels.
-
Levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's disease
This trial will test whether the anti-seizure medicine levetiracetam can prevent tonic-clonic seizures and slow cognitive decline in adults over 40 who have Down syndrome and symptomatic Alzheimer's disease.
-
Recognizing seizures in the intensive care unit
This project tests how well NHS neurophysiology scientists, neurologists, intensivists, and ICU nurses can identify seizures from digital video recordings of ICU events.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.